Drug discovery could be significantly accelerated thanks to a new high precision machine-learning model, developed by an international collaboration of researchers, including the University of Warwick.
The algorithm – partly devised by Dr James Kermode from Warwick’s School of Engineering – can accurately predict the interactions between a protein and a drug molecule based on a handful of reference experiments or simulations.
Using just a few training references, it can predict whether or not a candidate drug molecule will bind to a target protein with 99% accuracy.
This is equivalent to predicting with near-certainty the activity of hundreds of compounds after actually testing them – by running only a couple dozen tests. The new method could accelerate the screening of candidate molecules thousands of times over.
The algorithm can also tackle materials-science problems such as modelling the subtle properties of silicon surfaces, and promises to revolutionise materials and chemical modelling – giving insight into the nature of intermolecular forces.
The approach, developed by scientists at the University of Warwick, the École polytechnique fédérale de Lausanne’s Laboratory of Computational Science and Modelling, the University of Cambridge, the UK Science and Technology Facilities Council and the U.S. Naval Research Laboratory, can also identify which parts of the molecules are crucial for the interaction.
Dr James Kermode, from the University of Warwick’s Warwick Centre for Predictive Modelling and the School of Engineering, commented on the research:
“This work is exciting because it provides a general-purpose machine learning approach that is applicable both to materials and molecules.
“The research is expected to lead to a significant increase in the accuracy and transferability of models used for drug design and to describe the mechanical properties of materials.”
The design of this algorithm, which combines local information from the neighbourhood of each atom in a structure, makes it applicable across many different classes of chemical, materials science, and biochemical problems.
The approach is remarkably successful in predicting the stability of organic molecules, as well as the subtle energy balance governing the silicon structures crucial for microelectronic applications, and does so at a tiny fraction of the computational effort involved in a quantum mechanical calculation.
The research illustrates how chemical and materials discovery is now benefitting from the Machine Learning and Artificial Intelligence approaches that already underlie technologies from self-driving cars to go-playing bots and automated medical diagnostics.
New algorithms allow us to predict the behaviour of new materials and molecules with great accuracy and little computational effort, saving time and money in the process.
Learn more: Drug discovery could accelerate hugely with Machine Learning
The Latest on: Drug discovery with machine learning
[google_news title=”” keyword=”drug discovery with machine learning” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Revealing Protein-Ligand Interactions Using AI Enables Drug Discoveryon April 26, 2024 at 7:34 am
Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML.
- Accelerating scientific and drug discovery in an AI-powered labon April 25, 2024 at 5:00 pm
and Purdue Institutes for Drug Discovery, Cancer Research and Integrative Neuroscience. With the goal of accelerating scientific discovery, his lab has been developing the artificial ...
- A shortcut for drug discovery: Novel method predicts on a large scale how small molecules interact with proteinson April 25, 2024 at 11:00 am
For most human proteins, there are no small molecules known to bind them chemically (so-called "ligands"). Ligands frequently represent important starting points for drug development but this ...
- AI drug discovery biotech Xaira Therapeutics launches with over $1bn in committed fundingon April 25, 2024 at 4:31 am
Xaira Therapeutics, a new biotech aiming to “re-engineer” drug discovery and development using artificial intelligence (AI), has launched with more than $1bn in committed funding.
- New AI drug discovery powerhouse Xaira rises with $1B in fundingon April 24, 2024 at 3:00 am
If you asked an AI to generate a brand-new drug discovery biotech with a team of some of the biggest names in the biz for you, it couldn’t dream up one like Xaira Therapeutics. | If you asked an AI to ...
- Machine Learning Reveals Sex Disparities in Heart Disease Diagnosison April 22, 2024 at 4:59 pm
Now, scientists have used machine learning to build new and improved models, which could especially improve risk prediction for women. They also found that for certain heart conditions, women are ...
- Artificial Intelligence and Machine Learning – Webinars and Online Eventson April 18, 2024 at 6:27 pm
To this end, the use of machine learning algorithms ... academia and pharmaceutical drug development, who want to hear from experts across their field. Focus will be given to the latest advances in ...
- Revolutionizing Parkinson’s Treatment: AI Accelerates Drug Discoveryon April 17, 2024 at 5:19 am
AI possibilities to establish a revolutionary treatment that rearranges the field of diagnostics and treatment of Parkinson's.
via Google News and Bing News